BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 8550831)

  • 1. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
    Hosokawa YA; Hosokawa H; Chen C; Leahy JL
    J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of proinsulin messenger RNA after partial pancreatectomy in rats. Relationships to glucose homeostasis.
    Orland MJ; Chyn R; Permutt MA
    J Clin Invest; 1985 Jun; 75(6):2047-55. PubMed ID: 3891788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
    Leahy JL; Bumbalo LM; Chen C
    Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
    Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative modulations of insulin secretion, pancreatic insulin content, and proinsulin mRNA in rats. Effects of 50% pancreatectomy and dexamethasone administration.
    Orland MJ; Permutt MA
    Diabetes; 1991 Feb; 40(2):181-9. PubMed ID: 1991569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
    Dachicourt N; Serradas P; Bailbé D; Kergoat M; Doaré L; Portha B
    J Endocrinol; 1997 Nov; 155(2):369-76. PubMed ID: 9415071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
    Weir GC; Mojsov S; Hendrick GK; Habener JF
    Diabetes; 1989 Mar; 38(3):338-42. PubMed ID: 2645190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired phasic insulin and amylin secretion in diabetic rats.
    Leahy JL; Fineman MS
    Am J Physiol; 1998 Sep; 275(3):E457-62. PubMed ID: 9725812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy.
    Leahy JL; Bonner-Weir S; Weir GC
    J Clin Invest; 1988 May; 81(5):1407-14. PubMed ID: 3284912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
    Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
    Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.
    Jia X; Elliott R; Kwok YN; Pederson RA; McIntosh CH
    Diabetes; 1995 May; 44(5):495-500. PubMed ID: 7729605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
    D'Alessio DA; Fujimoto WY; Ensinck JW
    Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo.
    Hargrove DM; Nardone NA; Persson LM; Andrews KM; Shepherd KL; Stevenson RW; Parker JC
    Metabolism; 1996 Mar; 45(3):404-9. PubMed ID: 8606650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated hexokinase activity in isolated islets from diabetic 90% pancreatectomized rats.
    Hosokawa H; Hosokawa YA; Leahy JL
    Diabetes; 1995 Nov; 44(11):1328-33. PubMed ID: 7589832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia.
    Liu YQ; Nevin PW; Leahy JL
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E68-73. PubMed ID: 10893324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated proinsulin biosynthesis in vitro from a rat model of non-insulin-dependent diabetes mellitus.
    Halban PA; Bonner-Weir S; Weir GC
    Diabetes; 1983 Mar; 32(3):277-83. PubMed ID: 6337906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on insulin production sorting and secretion by major histocompatibility complex class II gene expression in the pancreatic beta-cell of transgenic mice.
    Grodsky GM; Ma YH; Cullen B; Sarvetnick N
    Endocrinology; 1992 Aug; 131(2):933-8. PubMed ID: 1639031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.
    Linn T; Schneider K; Göke B; Federlin K
    Acta Diabetol; 1996 Mar; 33(1):19-24. PubMed ID: 8777280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular responses of islets during perturbations of glucose homeostasis determined by in situ hybridization histochemistry.
    Chen L; Komiya I; Inman L; McCorkle K; Alam T; Unger RH
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1367-71. PubMed ID: 2645581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.